Cargando…

Single-Cell Transcriptome Profiling Unravels Distinct Peripheral Blood Immune Cell Signatures of RRMS and MOG Antibody-Associated Disease

Relapsing-remitting multiple sclerosis (RRMS) and myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) are inflammatory demyelinating diseases of the central nervous system (CNS). Due to the shared clinical manifestations, detection of disease-specific serum antibody of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ju, Yang, Xiaoyan, Pan, Jiali, Wei, Zhihua, Liu, Peidong, Chen, Min, Liu, Hongbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795627/ https://www.ncbi.nlm.nih.gov/pubmed/35095746 http://dx.doi.org/10.3389/fneur.2021.807646

Ejemplares similares

A Case of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Peripheral Neuropathy With Positive Anti-Myelin Oligodendrocyte (MOG) Antibodies
por: Yousuf, Kauser, et al.
Publicado: (2023)

IV/IT hUC-MSCs Infusion in RRMS and NMO: A 10-Year Follow-Up Study
por: Lu, Zhengjuan, et al.
Publicado: (2020)

Neurological update: MOG antibody disease
por: Wynford-Thomas, Ray, et al.
Publicado: (2018)

Investigating the association between neoplasms and MOG antibody-associated disease
por: Trentinaglia, Milena, et al.
Publicado: (2023)

Predictors of relapse in MOG antibody associated disease: a cohort study
por: Huda, Saif, et al.
Publicado: (2021)

Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort
por: Manzano, Giovanna S., et al.
Publicado: (2022)

Descriptive Analysis of Real-World Data on Fingolimod Long-Term Treatment of Young Adult RRMS Patients
por: Ziemssen, Tjalf, et al.
Publicado: (2021)

Distinct binding properties of TIAR RRMs and linker region
por: Kim, Henry S., et al.
Publicado: (2013)

Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
por: Borisow, Nadja, et al.
Publicado: (2018)

Value of Area Postrema Syndrome in Differentiating Adults With AQP4 vs. MOG Antibodies
por: Hyun, Jae-Won, et al.
Publicado: (2020)

The Expanding Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease in Children and Adults
por: Parrotta, Erica, et al.
Publicado: (2020)

A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
por: Hochmeister, Sonja, et al.
Publicado: (2020)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
por: Cross, Helen, et al.
Publicado: (2021)

A case report of neurosyphilis coexisting with a positive MOG antibody manifested as optic neuritis
por: Shi, Min, et al.
Publicado: (2023)

Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel
por: Brill, Livnat, et al.
Publicado: (2021)

Clinical Features of Coexisting Anti-NMDAR and MOG Antibody-Associated Encephalitis: A Systematic Review and Meta-Analysis
por: Ding, Jiayue, et al.
Publicado: (2021)

The MOG antibody associated encephalitis preceded by COVID-19 infection; a case study and systematic review of the literature
por: Borończyk, Michał, et al.
Publicado: (2023)

Identification of circulating MOG-specific B cells in patients with MOG antibodies
por: Winklmeier, Stephan, et al.
Publicado: (2019)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
por: Jurynczyk, Maciej, et al.
Publicado: (2017)

Clinical features of patients with MOG-IgG associated disorders and analysis of the relationship between fibrinogen-to-albumin ratio and the severity at disease onset
por: Li, Yue, et al.
Publicado: (2023)

Pattern Visually Evoked Potentials in Japanese Girl With Optic Neuritis and Seropositive to Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Takano, Shunichiro, et al.
Publicado: (2019)

Bilateral Acute Optic Perineuritis Associated With COVID-19 in a Patient With Seronegative Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Ali, Liaquat, et al.
Publicado: (2021)

MOG Antibody-Associated Disorders Following SARS-CoV-2 Vaccination: A Case Report and Literature Review
por: Matsumoto, Yuki, et al.
Publicado: (2022)

Characterization of peripheral white blood cells transcriptome to unravel the regulatory signatures of bovine subclinical mastitis resistance
por: Yang, Jinyan, et al.
Publicado: (2022)

Association of Circulating Follicular Helper T Cells and Serum CXCL13 With Neuromyelitis Optica Spectrum Disorders
por: Yang, Xiaoyan, et al.
Publicado: (2021)

Case report: MOG-IgG-associated encephalitis with Epstein-Barr virus infection and Alzheimer's pathologic change in cerebrospinal fluid
por: Li, Lin, et al.
Publicado: (2022)

MOG antibodies in combined central and peripheral demyelination syndromes
por: Vazquez Do Campo, Rocio, et al.
Publicado: (2018)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Diseases in Children in Central South China: Clinical Features, Treatments, Influencing Factors, and Outcomes
por: Mao, Leilei, et al.
Publicado: (2019)

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
por: Bollo, Luca, et al.
Publicado: (2021)

Th17 cells increase in RRMS as well as in SPMS, whereas various other phenotypes of Th17 increase in RRMS only
por: Kalra, S, et al.
Publicado: (2020)

Recent developments in MOG-IgG associated neurological disorders
por: Hegen, Harald, et al.
Publicado: (2020)

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
por: Ren, Bing-Yan, et al.
Publicado: (2021)

Structural and Functional Alterations in Visual Pathway After Optic Neuritis in MOG Antibody Disease: A Comparative Study With AQP4 Seropositive NMOSD
por: Gao, Chenyang, et al.
Publicado: (2021)

Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD
por: Yan, Yaping, et al.
Publicado: (2016)

Possible coexistence of MOG-IgG-associated disease and anti-Caspr2 antibody-associated autoimmune encephalitis: a first case report
por: Liu, Pei, et al.
Publicado: (2020)

Oral available agents in the treatment of RRMS
por: Aupérin, Thierry
Publicado: (2013)

Impact of drug diversity on treatment effectiveness in relapsing-remitting multiple sclerosis (RRMS) in Germany between 2010 and 2018: real-world data from the German NeuroTransData multiple sclerosis registry
por: Braune, Stefan, et al.
Publicado: (2021)

Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS
por: Ghezzi, Angelo, et al.
Publicado: (2019)

Humoral signatures of MOG-antibody-associated disease track with age and disease activity
por: Spatola, Marianna, et al.
Publicado: (2023)

Peripherally derived macrophages as major phagocytes in MOG encephalomyelitis
por: Kwon, Young Nam, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l48upiaqm5g2553mnt5bgn069e